ResMed Inc News

Top Brokers Name 3 ASX Shares to Buy Next Week 5 May 2024

It has been another busy week for Australia's top brokers. This has led to the release of a number of broker notes.

The Motley FoolMay 4 17:35 ET

ResMed Inc. (NYSE:RMD) Looks Interesting, And It's About To Pay A Dividend

Yahoo FinanceMay 3 06:55 ET

ResMed Inc Reports Monthly CDI Fluctuations

TipRanksMay 2 22:07 ET

ResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcript

Yahoo FinanceApr 30 13:31 ET

ResMed Inc. Just Recorded A 15% EPS Beat: Here's What Analysts Are Forecasting Next

Yahoo FinanceApr 30 06:12 ET

Leading Brokers Name 3 ASX Shares to Buy Today 29 April 2024

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

The Motley FoolApr 29 00:05 ET

Why Is the ResMed Share Price Surging Again and up 14% in Two Sessions?

The ResMed Inc. (ASX: RMD) share price is storming higher again on Monday.

The Motley FoolApr 28 21:14 ET

ResMed's Gross Margin Was a 3Q Highlight -- Market Talk

0006 GMT - The strength of ResMed's 3Q gross margin was the biggest positive surprise for Morgan Stanley analyst Sean Laaman. The breathing-tech provider's gross margin was about 90 basis points stron

WSJApr 28 20:07 ET

ResMed Price Target Raised 9% to A$36.00/Share by Wilsons

ResMed Price Target Raised 9% to A$36.00/Share by Wilsons

Dow JonesApr 28 18:56 ET

ResMed Inc. Files Compliant Quarterly Report

TipRanksApr 28 18:27 ET

Decoding ResMed Inc (RMD): A Strategic SWOT Insight

Yahoo FinanceApr 27 01:06 ET

These Stocks Are Moving the Most Today: Alphabet, Microsoft, Intel, Snap, Exxon, Roku, Skechers, ResMed, and More -- Barrons.com

By Joe Woelfel Stocks posted solid gains Friday, rebounding from sharp losses Thursday, following strong earnings from tech giants Alphabet and Microsoft. Equities traded higher even as the Federal R

Barron'sApr 26 14:24 ET

ResMed Price Target Cut to $200.00/Share From $205.00 by Oppenheimer

ResMed Price Target Cut to $200.00/Share From $205.00 by Oppenheimer

Dow JonesApr 26 14:05 ET

ResMed Is Maintained at Sector Perform by RBC Capital

ResMed Is Maintained at Sector Perform by RBC Capital

Dow JonesApr 26 12:03 ET

ResMed Stock Soars 15% After Strong Earnings

By Emily Dattilo Shares of ResMed were trading sharply higher after the medical devices company filed a quarterly report that left Wall Street cheering. In premarket trading Friday, ResMed stock was

Barron'sApr 26 10:29 ET

ResMed Up Over 14%, on Pace for Largest Percent Increase Since March 2020 -- Data Talk

ResMed Inc. (RMD) is currently at $209.44, up $26.02 or 14.19% --Would be highest close since Aug. 3, 2023, when it closed at $219.95 --On pace for largest percent increase since March 17, 2020, whe

Dow JonesApr 26 10:07 ET

Research Alert: CFRA Maintains Hold Opinion On Shares Of Resmed Inc.

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price by

MT NewswiresApr 26 09:45 ET

S&P 500 Futures Climb In Premarket Trading; Snap, Alphabet Lead

This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Snap Inc. (SNAP) was up 26.0% in pre-market trading

Dow JonesApr 26 07:31 ET

ResMed Shares Climb on Strong 3Q Results

By Dean Seal Shares of ResMed jumped after the company reported higher fiscal third-quarter earnings and revenue than analysts had been expecting. The stock was up 12% at $204.87 in premarket tradin

WSJApr 26 06:53 ET

ResMed Price Target Raised to $236.00/Share From $224.00 by Needham

ResMed Price Target Raised to $236.00/Share From $224.00 by Needham

Dow JonesApr 26 06:35 ET